COMMUNIQUÉS West-GlobeNewswire

Takeda et TiGenix annoncent les résultats de la première période d'acceptation pour l'offre publique d'acquisition volontaire et conditionnelle de TiGenix et le début de la deuxième période d'accep...
06/06/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS RÈGLEMENTÉES INFORMATIONS PRIVILÉGIÉES Takeda et TiGenix annoncent les résultats de la première période d'acceptation pour l'offre publique d'acquisition volontaire et conditionnelle de [...]
MDxHealth launch agreement with Philips for prognostic prostate cancer biomarker
06/06/2018
NEWS RELEASE MDxHealth announces worldwide licencing agreement with Philips for prognostic prostate cancer biomarker Agreement with Philips facilitates the launch of InformMDx(TM) HERSTAL, BELGIUM and IRVINE, CA - 07:00 [...]
MDxHealth annonce de licence avec Philips pour un biomarqueur du cancer de la prostate
06/06/2018
COMMUNIQUÉ DE PRESSE MDxHealth annonce la conclusion d'un contrat de licence mondial avec Philips pour un biomarqueur du cancer de la prostate Conclusion d'un contrat avec Philips : un pas de plus vers le lancement d' [...]
argenx receives feedback from FDA in end-of-phase 2 meeting for efgartigimod in myasthenia gravis
06/06/2018
- Global pivotal Phase 3 clinical trial of efgartigimod in myasthenia gravis on track to initiate before end of 2018 - June 6, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a [...]
Kraig Biocraft Laboratories provides a statement on the market's response to recent Company milestones and the creation of its Vietnamese subsidiary
06/06/2018
ANN ARBOR, Mich., June 05, 2018 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers announces today that it is continuing its efforts to [...]
Healthcare of Ontario Pension Plan honours Canadian properties and tenants in its portfolio at seventh annual LEAP Awards
06/06/2018
TORONTO, June 05, 2018 (GLOBE NEWSWIRE) -- Today, The Healthcare of Ontario Pension Plan (HOOPP) honoured the outstanding sustainability achievements and leadership of management teams and tenants in HOOPP’s real estate [...]
Compass Cannabis Clinics Announces Licensed Retail Outlet in Saskatchewan
06/06/2018
CALGARY, Alberta, June 05, 2018 (GLOBE NEWSWIRE) -- 10330698 Canada Ltd. (dba Compass Cannabis Clinics, "Compass Cannabis") is pleased to announce the success of its subsidiary, 10537888 Canada Ltd. (or "the Company" [...]
Great Canadian Healthcare Debate Result: Health Leaders Make Universality of Mental Health their Top Priority
05/06/2018
ST. JOHN’S, Newfoundland, June 05, 2018 (GLOBE NEWSWIRE) -- The Great Canadian Healthcare Debate – a marquee feature of the National Health Leadership Conference revealed that universal mental health Care must be a top [...]
Résultat du Grand débat sur les soins de santé au Canada : les leaders en santé font de l’universalité de la santé mentale leur principale priorité
05/06/2018
ST. JOHN’S, Terre-Neuve, 05 juin 2018 (GLOBE NEWSWIRE) -- Le Grand débat sur les soins de santé au Canada, l’un des faits saillants de la Conférence nationale sur le leadership en santé, s’est soldé par le choix de l’ [...]
Chimerix to Address Congressional Subcommittee in Support of Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA)
05/06/2018
DURHAM, N.C., June 05, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, announced that President and Chief Executive Officer M. [...]
Teligent, Inc. Announces Closing Of $25 Million Secured Credit Facility
05/06/2018
BUENA, N.J., June 05, 2018 (GLOBE NEWSWIRE) -- TELIGENT, Inc. (NASDAQ:TLGT) Teligent, Inc. (“Teligent”) announced today that it has entered into a Credit Agreement with certain funds managed by Highbridge Capital [...]
Portola Pharmaceuticals to Present at Two Upcoming Investor Conferences
05/06/2018
SOUTH SAN FRANCISCO, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq:PTLA) today announced that the company will present at the following conferences in June: Goldman Sachs 39 th Annual [...]
MannKind Establishes Market Price Stock Purchase Plan
05/06/2018
WESTLAKE VILLAGE, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) has established a stock purchase plan that provides MannKind’s directors and executive officers with a way to purchase [...]
MacroGenics to Present at Jefferies Global Healthcare Conference
05/06/2018
ROCKVILLE, MD, June 05, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Madrigal Pharmaceuticals Announces Proposed Public Offering of Common Stock
05/06/2018
CONSHOHOCKEN, Pa., June 05, 2018 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq:MDGL), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutic [...]
GBT Announces New Employment Inducement Grants
05/06/2018
SOUTH SAN FRANCISCO, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that, on June 1, 2018, the compensation committee of the Company’s board of directors [...]
Akcea Therapeutics Appoints Industry Leader Dr. Richard Moscicki to Board of Directors
05/06/2018
CAMBRIDGE, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., today announced the appointment of Richard (Rich) A. Moscicki, M.D., to the [...]
Aptose Biosciences Announces Results of Annual Meeting of Shareholders
05/06/2018
SAN DIEGO and TORONTO, June 05, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics targeting the [...]
VBL Therapeutics Presents Positive Data on its MOSPD2 Platform Technology in Oncology and Inflammation at BIO 2018
05/06/2018
TEL AVIV, Israel, June 05, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT) today presented data on its novel MOSPD2 program in oncology and inflammation at the 2018 BIO International Convention in Boston, [...]

Pages